These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1018 related articles for article (PubMed ID: 11752403)

  • 1. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.
    Vaisman BL; Lambert G; Amar M; Joyce C; Ito T; Shamburek RD; Cain WJ; Fruchart-Najib J; Neufeld ED; Remaley AT; Brewer HB; Santamarina-Fojo S
    J Clin Invest; 2001 Jul; 108(2):303-9. PubMed ID: 11457883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
    Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
    Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
    J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet.
    Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S
    Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
    Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
    Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
    Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
    PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice.
    Yu Y; Luo T; Liu S; Song G; Han J; Wang Y; Yao S; Feng L; Qin S
    J Atheroscler Thromb; 2015; 22(9):926-41. PubMed ID: 25843117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis.
    Feng Y; Lievens J; Jacobs F; Hoekstra M; Van Craeyveld E; Gordts SC; Snoeys J; De Geest B
    Cardiovasc Res; 2010 Nov; 88(2):376-85. PubMed ID: 20562425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased ABCA1 activity protects against atherosclerosis.
    Singaraja RR; Fievet C; Castro G; James ER; Hennuyer N; Clee SM; Bissada N; Choy JC; Fruchart JC; McManus BM; Staels B; Hayden MR
    J Clin Invest; 2002 Jul; 110(1):35-42. PubMed ID: 12093886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
    Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis.
    Vaisman BL; Demosky SJ; Stonik JA; Ghias M; Knapper CL; Sampson ML; Dai C; Levine SJ; Remaley AT
    J Lipid Res; 2012 Jan; 53(1):158-67. PubMed ID: 22039582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet.
    Baroukh N; Ostos MA; Vergnes L; Recalde D; Staels B; Fruchart J; Ochoa A; Castro G; Zakin MM
    FEBS Lett; 2001 Jul; 502(1-2):16-20. PubMed ID: 11478940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
    Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global functional knockdown of ATP binding cassette transporter A1 stimulates development of atherosclerosis in apoE K/O mice.
    Mukhamedova N; D'Souza W; Low H; Kesani R; Chimini G; Sviridov D
    Biochem Biophys Res Commun; 2011 Sep; 412(3):446-9. PubMed ID: 21839726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triacetyl-3-hydroxyphenyladenosine, a derivative of cordycepin, attenuates atherosclerosis in apolipoprotein E-knockout mice.
    Zhao Z; Song G; Tian H; Yu Y; Tian X; Liu J; Yao S; Luo T; Qin S
    Exp Biol Med (Maywood); 2012 Nov; 237(11):1262-72. PubMed ID: 23239437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.
    Brunham LR; Singaraja RR; Duong M; Timmins JM; Fievet C; Bissada N; Kang MH; Samra A; Fruchart JC; McManus B; Staels B; Parks JS; Hayden MR
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):548-54. PubMed ID: 19201688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.